Chenglin Wu
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments 15
-
- Invertebrate Immune Response Mechanisms 2
-
- Vibrio bacteria research studies 3
-
- Organ Donation and Transplantation 12
-
- Organ Transplantation Techniques and Outcomes 9
-
- Renal and Vascular Pathologies 3
-
- Renal Diseases and Glomerulopathies 2
-
- CRISPR and Genetic Engineering 2
- Co-authors
- Yuanqing ZhangJizhou TanJiaping LiLijun ZhouJie ZhangJialang ZhuangTing LiuChunhai Fan
- Journals
- Nucleic Acids Research (1 paper)The Journal of Immunology (1 paper)Journal of Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Chenglin Wu
42 papers receiving 757 citations
Peers
Comparison fields: 5 of 105
- Transplantation 45
- Immunology 189
- Endocrinology 29
- Cancer Research 84
- Oncology 143
Countries citing papers authored by Chenglin Wu
This map shows the geographic impact of Chenglin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglin Wu more than expected).
Fields of papers citing papers by Chenglin Wu
This network shows the impact of papers produced by Chenglin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglin Wu. The network helps show where Chenglin Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chenglin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 56 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 2 | |
| 8 | 2022 | 3 | |
| 9 | 2022 | 47 | |
| 10 | 2022 | 4 | |
| 11 | 2020 | 10 | |
| 12 | 2020 | 139 | |
| 13 | 2020 | 35 | |
| 14 | 2019 | 21 | |
| 15 | 2019 | 4 | |
| 16 | 2019 | 48 | |
| 17 | 2018 | 44 | |
| 18 | 2016 | 13 | |
| 19 | 2012 | 45 | |
| 20 | 2011 | 35 |
About Chenglin Wu
Chenglin Wu is a scholar working on Transplantation, Endocrinology and Immunology, having authored 47 papers that have together received 767 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (15 papers), Organ Donation and Transplantation (12 papers), Organ Transplantation Techniques and Outcomes (9 papers), Vibrio bacteria research studies (3 papers), Renal and Vascular Pathologies (3 papers), Invertebrate Immune Response Mechanisms (2 papers), Renal Diseases and Glomerulopathies (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Transplantation (45 citations), Immunology (189 citations) and Endocrinology (29 citations). Chenglin Wu has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Yuanqing Zhang, Jizhou Tan, Jiaping Li, Lijun Zhou, Jie Zhang, Jialang Zhuang, Ting Liu, Chunhai Fan, Jianfei Liu and Kenneth Söderhäll. Their work appears in journals such as Nucleic Acids Research, The Journal of Immunology and Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.